Reducing the Acute Care Burden of Childhood Asthma on Health Services in British Columbia

Phase 4

Completed

• Conditions: Asthma; Upper Respiratory Tract Infection
• Interventions: Drug: Arm 1 Oral Cortico Steroids

• Registration Number: NCT01326494
• Lead Sponsor: University of British Columbia

Brief Summary

The purpose of this study is to investigate the benefits of giving filled prescription of a medication to be used upon early onset of symptoms of URTI induced asthma. The hope is to reduce the need to present to Health Care centres for treatment.

Detailed Description

In Canada, asthma affects more the 12% of children. Exacerbation are a common feature of asthma. In children, upper respiratory tract infection (URTI's) are responsible for over 80% of asthma exacerbation.

Experts in asthma care acknowledge this critical problem and have developed guidelines to reduce asthma exacerbation.

The criteria for participation in this study to have 2 or more presentations to a Health Service centre in the past 12 months for URTI induced asthma. These patients will be followed and interviewed monthly over a 12 month period to investigate whether the use of Oral cortico-steroids upon early onset of URTI induced asthma prevents the need for presentation to hospital

Study Timeline

• Study First Submitted: 2011-03-29
• Study First Submitted QC: 2011-03-29
• Study First Posted: 2011-03-31
• Study Start: 2011-04
• Primary Completion: 2012-05
• Status Verified: 2021-05
• Study Completion: 2021-05
• Last Update Submitted: 2021-05-13
• Last Update Posted: 2021-05-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 92

Inclusion Criteria

• 2 or more presentations to Emergency department in a 12 month period

Exclusion Criteria

• less then 2 presentations to Emergency department in a 12 month period

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Arm 1 Oral Cortico Steroid	Arm 1 Oral Cortico Steroids	A filled prescription will be given to be used upon early onset of symptoms.

Primary Outcome Measures

Name	Time	Method
Reduction of representation to Health Services for Exacerbation of URTI induced asthma	One year	To review the effect of medication given at early onset of symptoms have on reducing the presentation to Health Services and Emergency Departments.

Trial Locations

Locations (1)

BC Children's Hospital; 🇨🇦 Vancouver, British Columbia, Canada